Medicrea published the results of a five-year study of its UNiD patient-specific rods.
More than 2,800 patients have received the patient-specific rods, which use the company's Adaptive Spine Intelligence. In the U.S., implant adoption has spiked 62 percent in 2018, and within the third quarter, adoption has increased 90 percent.
The recent study comprised 60 patients. At the one-year follow-up, the average pedicle screws construct was of 6.4 levels . The results were published in Clinical Spine Surgery.
Four surgeons were involved in the study of the UNiD implants. Here are their conclusions:
1. Federico Solla, MD. He emphasized the benefits patients have experienced, including decreased mechanical complications and reduced operating time. Surgeons also do not have to bend rods during surgery, according to Dr. Solla.
2. Evalina Burger, MD. "These results support the use of the UNiD ASI platform to obtain the expected patient-specific sagittal balance with a special focus on the difference pelvic incidence – lumbar lordosis."
3. Christopher Kleck, MD. "With its proprietary UniD ASI technology, Medicrea started revolutionizing the spine world by developing a model taking into consideration compensatory mechanisms to individually predict each patient's outcomes."
4. Vincent Fiere, MD. "With Medicrea's breakthrough technology, we showed that patients implanted with UNiD [patient-specific rods] were 2.6 times more likely to be optimally corrected."